4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-19-002141
Senior VP - CCO sold 954 shares at $9.20 ($8,777)
- Senior VP - CCO acquired 954 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Powell Lynne · Senior VP - CCO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-01-14 | Exercise or conversion : show line 1 in the form | +954 | $3.22 | $3,072 | 954 | D |
| 2019-01-14 | Sale : show line 2 in the form | −954 | $9.20 | $8,777 | 0 | D |
| Open-market sales · 954 sh · avg $9.20 · $8,777 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-01-14 | Exercise or conversion : show line 3 in the form Emp. Stock Option (Right to Buy) | −954 | 96,473 | D |
Loading xslF345X03/form4.xml…